Newly diagnosed cases of HIV in those aged 50 years and older and those less than 50: 2008–2017

Abstract

Background

Canada’s population is aging, with nearly forty percent of Canadians aged 50 years or more. As the population ages, unique challenges related to health are becoming evident, including increasing rates of sexually transmitted and bloodborne infections. Understanding the epidemiology of HIV in older adults is important to guide prevention and control programs.

Objective

To assess trends in newly diagnosed cases of HIV in Canada among those aged 50 years and older (≥50 years) and those aged less than 50 (<50 years), and to compare their basic demographic characteristics and exposure categories for the period of 2008 to 2017.

Methods

National surveillance of HIV is conducted by the Public Health Agency of Canada through voluntary submission of data by provincial/territorial public health authorities. Descriptive analyses were conducted on reported cases of HIV between January 1, 2008, to December 31, 2017 to compare the demographic profiles and exposure category for the two age groups.

Results

Between 2008 and 2017, the proportion of newly diagnosed HIV cases among those ≥50 years increased from 15.1% to 22.8%. The HIV diagnosis rates for both older males and older females increased over time, with a relatively higher increase for females. A higher proportion of newly diagnosed HIV cases were male in the older group (81.2%) compared to the younger group (74.6%). Among both older and younger males, the most common exposure category for HIV was being gay, bisexual and other men who have sex with men (gbMSM), followed by heterosexual contact and injection drug use; however, the relative proportions varied by age with the gbMSM category being higher in the <50 group.

Conclusion

In Canada, over 20% of all newly diagnosed cases of HIV are now in people 50 years of age and older. HIV testing and prevention initiatives, historically aimed at younger populations, may not have the same impact for older populations. These data can be used to inform future public health actions designed to address HIV in older populations.

Introduction

Globally, there were an estimated 36.9 million individuals living with HIV in 2017 (1), and more than 10% of the adult population living with HIV in low and middle-income countries is estimated to be 50 years of age or older (≥50 years) (2). In developed nations, those ≥50 years comprise an estimated 30% of adults living with HIV (3). Due to continued advances in HIV treatment, the number and proportion of people living with HIV at an older age is likely to continue to grow (4); it is predicted that the number of those ≥50 years living with HIV in low and middle-income will increase by 47% to 6.9 million by 2020 (5).

The proportion of Canada’s population aged ≥50 years has increased 12.7% in the past five years and is now nearly 40% (6). As Canadians grow older (and live longer), they face a number of challenges related to the maintenance and promotion of health. For older Canadians living with HIV, they also live with the possibility of accelerated aging, side effects of prolonged antiretroviral use (7) and higher rates of non-AIDS-related comorbidities such as diabetes, cancer and cardiovascular disease (4,8). Thus, the HIV epidemic poses serious concerns in older adults because of physical, mental and psychological issues that accompany both aging and HIV infection (9,10). With aging national and global populations, understanding the epidemiology of HIV in older adults is important to help guide awareness and prevention programs.

The objective of this analysis is to assess trends in newly diagnosed cases of HIV in Canada in populations ≥50 years of age and those younger than 50 years (<50 years), and to compare the basic demographic characteristics and exposure categories of these two populations for the period of 2008 to 2017.

Methods

The study used data from the national HIV/AIDS Surveillance System (HASS) maintained by the Public Health Agency of Canada (PHAC) (11). The HASS is a passive, case-based surveillance system that collates non-nominal data on persons newly diagnosed with HIV in Canada and submitted to PHAC by provincial and territorial public health authorities. Details on the surveillance methods have been described previously (11,12).

Data on age, sex and exposure categories were analyzed in cases of HIV reported between January 1, 2008 and December 31, 2017. Cases were stratified into two groups: one composed of those ≥50 years at diagnosis; and one composed of those <50 years at diagnosis. The exposure categories used in HIV surveillance are noted in Table 1 and are used in a hierarchy (11) to reflect the single most likely mode of transmission for HIV even if the case had multiple exposures categories.

Table 1. List of exposure categories and descriptions used in HIV national surveillance (11).

Exposure Category	Reported type of exposure
Gay, bisexual and other men who have sex with men (gbMSM)	Male-to-male sexual contact
People who inject drugs (PWID)	Use of injection drugs
gbMSM-PWID	Male-to-male sex and the use of injection drugs
Heterosexual/endemica (Het-Endemic)	A person born in a country where HIV is endemic who reports heterosexual sex
Heterosexual/risk (Het-Risk)	Heterosexual sex with someone who is either HIV-infected or who is at increased risk of HIV infection (e.g. a person who injects drugs, a male who has male sex partners or a person from an HIV-endemic country)
Heterosexual/no identified risk (Het-NIR)	Heterosexual sex, when heterosexual contact is the only risk factor reported and nothing is known about the HIV-related factors associated with the partner
Other	Perinatal exposure, occupational exposure or receipt of transfusion of blood or clotting factors, out of country, and any other exposure

^a The Public Health Agency of Canada defines countries where HIV is endemic as those countries where the prevalence of HIV among adults (age 15–49 years) is 1.0% or greater and one of the following criteria also applies: 50% or more of newly diagnosed HIV cases are attributed to heterosexual transmission; a male to female ratio of 2:1 or less among prevalent infections; or HIV prevalence greater than or equal to 2% among women receiving prenatal care

Quebec does not submit data on exposure category to PHAC so newly diagnosed cases from Quebec were excluded from analyses involving exposure category. Separate Chi-square tests were conducted to compare the distribution of exposure categories between the older and younger groups for both males and females. All rates were calculated using population denominators from the Annual Demographic Statistics, issued by Statistics Canada (13).

Results

There were 22,534 newly diagnosed cases of HIV between 2008 and 2017 and virtually all of the cases (99.8%) included data on age (n=22,486). Overall, 19.7% of these individuals (n=4,438) were ≥50 years of age, representing a 39.1% increase in the number of newly diagnosed cases of HIV in that group. The number of new HIV diagnoses for those ≥50 years of age increased from 15.1% in 2008 to 22.8% in 2017 (Figure 1). Similarly, the HIV diagnosis rate among this older age category increased from 3.5 per 100,000 population in 2008 to 3.9 per 100,000 population in 2017. The HIV diagnosis rate for the younger group was higher than for the older group, and fluctuated over this period, but decreased from 9.9 per 100,000 population in 2008 to 8.0 per 100,000 population in 2017.

Figure 1.

Reported numbers and rates (per 100,000 population) of HIV diagnoses in older (≥50 years), younger (<50 years) and all Canadians where age was reported, 2008–2017^a

Population data source: Annual Demographic Statistics, Statistics Canada (13)

^a Excludes cases with unknown age at HIV diagnosis

Age group and sex distribution

From 2008 to 2017, data on age and sex were available for 22,413 (99.4%) of the 22,534 newly diagnosed HIV cases. Of those, 81.2% were males in ≥50 years of age compared with 74.6% in males <50 years (data not shown). The corresponding rates of HIV diagnosis were higher in males than females in both age groups. The rate for both males and females ≥50 years of age increased over time, with the relative increase being higher among females (from 1.0 to 1.6 per 100,000 population for females and from 6.6 per 100,000 to 6.5 per 100,000 population for males). In those <50 years of age, rates for both males and females decreased over time, with the decrease among females being proportionately greater (from 5.6 per 100,000 population to 4.2 per 100,000 for females, and from 14.1 per 100, 000 population to 11.7 per 100,000 population for males) (Figure 2).

Figure 2.

Annual rates (per 100,000 population) of new HIV diagnoses by age category and sex, Canada, 2008–2017^a,b

Abbreviations: ≥50, age 50 years and older; <50, younger than 50 years of age

^a Population data source: Annual Demographic Statistics, Statistics Canada (13)

^b Excludes cases where age at HIV diagnosis is unknown. Excludes cases where sex is transgender, transsexual, other, unknown or not reported

Exposure category distribution

From 2008 to 2017, there were 14,751 new HIV diagnoses with known age, sex and exposure category (65%). Since the gay, bisexual and other men who have sex with men (gbMSM) exposure category only applied to males, analysis of the exposure category variable was done separately by sex. Among both older and younger males, gbMSM was the most common exposure category, followed by heterosexual contact and the injection drug use exposure categories. There were more younger males in the gbMSM (62.4%) than in the older males (48.0%). Conversely, there were fewer males who identified the heterosexual contact category in the younger group (18.3%) than the older group (32.0%). The proportion attributed to the injection drug use category was similar in both groups: 14.4% among older males; and 12.5% among younger males (Table 2).

Table 2. Number and proportion of newly diagnosed HIV cases by age category, sex and exposure category—Canada (excluding Quebec), 2008–2017^a–c.

Exposure category	Males				Females
	Younger than 50 years		50 years and older		Younger than 50 years		50 years and older
	n	%	n	%	n	%	n	%
gbMSM	5,723	62.4	957	48.0	N/A	0.0	N/A	0.0
gbMSM/PWID	348	3.8	47	2.4	N/A	0.0	N/A	0.0
PWID	1,150	12.5	288	14.4	898	29.0	78	16.0
Othera	277	3.0	63	3.2	244	7.9	44	9.0
Heterosexual contact	1,675	18.3	639	32.0	1,953	63.1	367	75.1
Het-Endemic	522	5.7	121	6.1	867	28.0	126	25.8
Het-Risk	464	5.1	240	12.0	620	20.0	129	26.4
Het-NIR	689	7.5	278	13.9	466	15.1	112	22.9
Subtotalb	9,173	-	1,994	-	3,095	-	489	-
No identifiable risk	403	3.0	152	4.2	143	3.1	27	3.2
Exposure category unknown or not reported (“missing”)	3,850	28.7	1,448	40.3	1,322	29.0	317	38.1
Total	13,426	-	3,594	-	4,560	-	833	-

Abbreviations: gbMSM, gay, bisexual and other men who have sex with men; Het-Endemic, heterosexual/endemic; Het-NIR, Heterosexual/no identifiable risk; Het-Risk, heterosexual/risk; N/A, not applicable; PWID; people who inject drugs; -, not applicable

^a “Other” includes clotting, blood, occupational exposure, out of country, perinatal, blood/clotting exposures and other

^b Includes only cases where age at HIV diagnosis, sex, and exposure category is known and reported

^c Chi-square test was significant (p<0.0001) when comparing between age groups for older and younger males, and also for older and younger females

Among females, heterosexual contact was the most frequent exposure category was highest in both age groups, but was relatively higher in ≥50 years of age (75.1% versus 63.1%). Conversely, the proportion of cases within the people who inject drugs exposure category was relatively higher in <50 years (29.0% vs 16.0%). Within the heterosexual contact exposure category, the proportion attributed to persons born in HIV-endemic countries was similar for both age categories (25.8% ≥50 years; 28.0% <50 years) (Table 2). The distribution of HIV diagnoses across exposure categories was significantly different between younger and older populations for both males and females (Chi-square test; p<0.0001).

From 2008 to 2017, the exposure category distribution by age did not change considerably for males or females (data not shown). For example, for males, gbMSM continued to be the most frequent of exposure category over time, whereas heterosexual contact continued to be the most frequent exposure category in females.

Discussion

In Canada, over 20% of all newly diagnosed cases of HIV are now in people 50 years of age and older. The number of new HIV diagnoses in the older age group increased by 39.1% from 2008 to 2017; likewise, the rate of new HIV diagnoses over this time also increased. This trend is in contrast to the younger age category, which experienced an overall decrease in both the proportion and rate of new HIV diagnoses over the same period; these changes over time were seen in both males and females, although the relative changes were greater among females. The largest proportion of new diagnoses was reported among the gbMSM exposure category, accounting for almost half of older males and two thirds of younger males.

The increasing trend in HIV diagnoses among older adults has been observed in other countries as well. The 20% incidence falls between the UNAIDS global estimates of 10% (for low and middle-income countries) (2) and 30% (for developed countries) (3). In the United Kingdom, the number of new HIV infections decreased over the years; whereas, the number and proportion of new diagnoses in people ≥50 years of age continued to increase (14). Comparatively, a recent analysis of data from the European Surveillance System compared older people (aged ≥50 years) to younger people (aged 15–49 years) in 2014 and 2015. The average notification rate of new diagnoses in older adults increased, primarily, in the eastern European Union/European Economic Area countries. The analysis also found that people ≥50 years of age are more likely to acquire HIV via heterosexual contact and to present late (15). In contrast, in the United States, HIV diagnoses among people ≥50 years decreased by 7% between 2011 and 2015 (16). This trend was also observed in New York City, where the number of new HIV diagnoses from 2001 to 2017 decreased significantly overall and for those ≥50 years (17).

Increased HIV testing may explain part of the increase in HIV diagnoses in older Canadians. British Columbia saw an overall increase in the rate of HIV testing since 2011, and the testing rates for those ≥50 years increased from 2011 to 2016 (18). A large proportion of new diagnoses were reported among the gbMSM exposure category (almost half for older males and two thirds for younger males), which remains the primary driver of the HIV epidemic in Canada (12). In general, the gbMSM population continues to be disproportionately affected by HIV. In Ontario, the percent of tests increased in the gbMSM population from 17.7% in 2007 to 28.6% in 2016 (19). Testing may also include HIV-negative gbMSM, who are at higher risk, since testing is the first step in considering preventative approaches such as preexposure prophylaxis (20).

In addition to these testing initiatives, there are several other possible reasons for the increasing proportions and rates in those ≥50 years of age, including low rates of condom use among older individuals (21–23), a lack of prioritization of HIV prevention efforts in older adults (24) and a tendency to a relatively late diagnosis in this population (23), enabling forward transmission. In the United States, older people (≥50 years) are more likely to have late-stage HIV infection at the time of diagnosis, and therefore start treatment later (16). Older adults are likely to be diagnosed with HIV-related medical disorders later in the course of their illness compared with their younger counterparts (25). In Canada, diagnoses of females who are ≥50 years of age have increased since 2008 and heterosexual contact was the most frequently reported exposure category for this age group (as well as for the younger females).

This increase in HIV diagnoses in older females could be partly due to older women being less concerned with the risks of pregnancy and, therefore maybe more likely to engage in unprotected sex (22,26–28). The observed increase in annually reported HIV diagnoses may also be attributed in part to previous positive HIV diagnoses, where a person may be tested and reported as a new diagnosis more than once due to inter-provincial migration or migration into Canada after a HIV diagnosis outside of Canada. However, for the time being it is not possible to assess the impact of previous diagnosis by age group, as this information is not available. The increase of newly diagnosed cases of HIV in adults who are ≥50 years of age has important implications. Older adults have different demographics and risk factors than younger adults, and testing and prevention initiatives, which have historically been aimed at a younger population, may not have the same effectiveness for an older population. Targeting interventions to the distinct characteristics of this older population may be required. PHAC will continue to provide updates on the status of HIV in this population as these data can be used to inform future public health actions designed to address HIV in older populations.

Limitations

While surveillance data describe the diagnosed portion of the epidemic, national HIV estimates of prevalence and incidence provide an overall picture of the HIV epidemic in Canada, and include people with both diagnosed and undiagnosed HIV infection (29). Data on new diagnoses represent only those individuals who have been tested and diagnosed with HIV, and do not represent the full spectrum of all people who are living with HIV. In addition, these data do not provide information on the time that these individuals were infected. The analysis in this study was limited to variables with relatively complete data, such as age, sex and exposure category. Finally, these data may include a subset of individuals who were previously diagnosed with HIV in another province (or country). Other limitations to HASS have been described elsewhere (12).

Conclusion

In Canada over 20% of all newly diagnosed cases of HIV are now in people 50 years of age and older. National HIV testing and prevention initiatives historically aimed at younger populations may not have the same impact for older populations. These data can be used to inform future public health actions designed to address HIV in older populations.